Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived

D J Dunican1, E J Williams, F V Howell

  • 1Molecular Neurobiology Group, MRC Centre for Developmental Neurobiology, Kings College London, London Bridge, London SE1 1UL, United Kingdom.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|May 25, 2001
PubMed

Insights

A novel phosphopeptide targeting fibroblast growth factor receptor (FGFR)-1 inhibits FGF-mediated cell growth. This peptide, FGFR730(p)Y, may block Shc protein binding, impacting mitogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Fibroblast growth factor receptor (FGFR)-1 activation involves tyrosine phosphorylation outside its catalytic site.
  • The physiological role of phosphorylation at Tyr730 on FGFR-1 remains debated, despite potential binding sites for phosphotyrosine-interacting molecules.

Purpose of the Study:

  • To investigate the functional significance of the Tyr730 residue in FGFR-1 signaling.
  • To determine if a phosphopeptide mimic of Tyr730 can inhibit FGF-mediated cellular responses.

Main Methods:

  • Synthesis of a cell-permeant phosphopeptide mimic of the FGFR-1 Tyr730 site (FGFR730(p)Y).
  • Assessing the effect of FGFR730(p)Y on FGF-mediated mitogenesis and responses to other growth factors.
  • Investigating the interaction of FGFR730(p)Y with intracellular signaling proteins, including Shc and components of the Erk-kinase cascade.

Main Results:

  • FGFR730(p)Y specifically inhibited FGF-mediated mitogenesis without affecting other growth factor responses.
  • The peptide did not inhibit phosphorylation of p90/FRS2 or Erk, indicating it does not block the Erk-kinase cascade.
  • FGFR730(p)Y demonstrated binding to Shc, dependent on both phosphorylated tyrosine and a PTB domain binding determinant.

Conclusions:

  • The Tyr730 site on FGFR-1 plays a role in FGF-mediated mitogenesis.
  • FGFR730(p)Y peptide inhibits mitogenesis likely by competing with the native FGFR-1 Tyr730 site for Shc binding.
  • These findings provide insights into FGFR-1 signaling pathways and potential therapeutic targets.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...